Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
Clinical trial NCT07259070 · RECRUITING
Trial details
- NCT number
- NCT07259070
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-29
- Primary completion
- 2029-11-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.